OrbiMed Israel BioFund GP Limited Partnership

Overview

• HeadquartersL3¹

See how the biggest companies compare on our leaderboards

Corporate structure

OrbiMed Israel BioFund GP Limited Partnership sits at the top of its group. 4 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (3 companies). Each entity in the chart links to its source.

Stakes it holds

OrbiMed Israel BioFund GP Limited Partnership has told the SEC it owns more than 5% of 3 companies, latest first (Schedules 13D and 13G).

• Chemomab Therapeutics Ltd.SCHEDULE 13D/A Jan 5, 2023 to Jun 23, 2025²
• Tessera Defense & Homeland Security Inc.SCHEDULE 13D/A Mar 17, 2023 to Jun 23, 2025³
• 9 METERS BIOPHARMA, INC.SC 13D/A Jul 1, 2022⁴